Pharmacoepidemiology in Neurodegenerative Disorders
Prof. Dr. Britta Hänisch
Group Leader
Kurt-Georg-Kiesinger-Allee 3
53175 Bonn

britta.haenisch@dzne.de
 +49 228 99307 5721

Publications

The complete list of publications is found here.

Fink A, Haenisch B. Oral antidiabetic drugs and dementia risk: Does treatment matter?. Neurology. 2017 Jan 01; doi: 10.1212/WNL.0000000000004613
Nadine Janis Pohontsch, Kathrin Heser, Antje Löffler, Britta Haenisch, Debora Parker, Tobias Luck, Steffi G. Riedel-Heller, Wolfgang Maier, Frank Jessen, Martin Scherer. General practitioners’ views on (long-term) prescription and use of problematic and potentially inappropriate medication for oldest-old patients - A qualitative interview study with GPs (CIM-TRIAD study). BMC Family Practice. 2017 Feb 16; 18 doi: 10.1186/s12875-017-0595-3
Anna Papazoglou, Julien Soos, Andreas Lundt, Carola Wormuth, Varun Raj Ginde, Ralf Müller, Christina Henseler, Karl Broich, Kan Xie, Dan Ehninger, Britta Haenisch, Marco Weiergräber. Gender-Specific Hippocampal Dysrhythmia and Aberrant Hippocampal and Cortical Excitability in the APPswePS1dE9 Model of Alzheimer's Disease. Neural Plasticity. 2015 Dec 31; 2016 doi: 10.1155/2016/7167358
Willy Gomm, Klaus Von Holt, Friederike Thomé, Karl Broich, Wolfgang Maier, Klaus Weckbecker, Anne Fink, Gabriele Doblhammer, Britta Haenisch. Regular Benzodiazepine and Z-Substance Use and Risk of Dementia: An Analysis of German Claims Data. Journal of Alzheimer's Disease. 2016 Sep 05; 54:801-808. doi: 10.3233/JAD-151006
Gomm W, von Holt K, Thome F, et al. Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis. JAMA Neurol. 2016 Jan 01; 73:410-416. doi: 10.1001/jamaneurol.2015.4791

Info-Hotline

Thursdays 1:30-4:30 pm

Patients +49 800-7799001

(free of charge)

Professionals +49 180-779900

(9 Cent/Min. German landline, mobile and out of Germany possibly more expensive)